Cargando…
Digoxin protects against intervertebral disc degeneration via TNF/NF-κB and LRP4 signaling
BACKGROUND: Intervertebral disc degeneration (IVDD) is a leading cause of low back pain (LBP). The pathological process of IVDD is associated with inflammatory reactions and extracellular matrix (ECM) disorders. Digoxin is widely used for treating heart failure, and it has been reported to have anti...
Autores principales: | Meng, Qunbo, Liu, Kaiwen, Liu, Zhenchuan, Liu, Jinbo, Tian, Ziyu, Qin, Shanshan, Wei, Jianlu, Cheng, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544936/ https://www.ncbi.nlm.nih.gov/pubmed/37790932 http://dx.doi.org/10.3389/fimmu.2023.1251517 |
Ejemplares similares
-
Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling
por: Liu, Kaiwen, et al.
Publicado: (2021) -
Suramin attenuates intervertebral disc degeneration by inhibiting NF-κB signalling pathway
por: Liu, Zi-Miao, et al.
Publicado: (2021) -
NF‐κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration
por: Zhang, Guang‐Zhi, et al.
Publicado: (2021) -
Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-κB pathway in rats
por: Wu, Xiexing, et al.
Publicado: (2018) -
miR‐640 aggravates intervertebral disc degeneration via NF‐κB and WNT signalling pathway
por: Dong, Wengang, et al.
Publicado: (2019)